Best Bloating Treatments: New Studies Change Advice
Best Treatment for Bloating, Based on New Studies
The best treatment for bloating right now is usually a stepwise, cause-targeted plan: start with dietary changes such as a short low-FODMAP trial or regular-meal advice, then match treatment to the likely driver, whether that is constipation, suspected bacterial overgrowth, visceral hypersensitivity, or a pelvic-floor problem. Recent reviews published in 2022 and 2024 also suggest that microbiome-focused strategies, especially rifaximin in selected patients and some targeted probiotics, may help, but the evidence is still stronger for certain subgroups than for bloating in general.
Why bloating happens
Bloating is not one condition; it is a symptom with several possible mechanisms, including excess fermentation, constipation, altered gas handling, visceral hypersensitivity, and abdomino-phrenic dyssynergia, where the diaphragm and abdominal wall respond abnormally after meals. That is why one person may improve with diet, another with constipation treatment, and another with breathing or biofeedback training.
In a 2024 review of functional abdominal bloating and distension, the authors reported that bloating and distension affect about 30% of adults overall, while functional bloating/distension as a Rome entity was estimated at about 3.5% and 1.2%, respectively. The same review noted that patients commonly report moderate to severe symptom burden and reduced daily functioning, which is why newer treatment advice focuses on identifying the dominant mechanism rather than using one universal remedy.
What new studies change
The newest studies do not point to a single miracle cure, but they do make the treatment hierarchy clearer. The strongest updates are that diet still matters, rifaximin remains the best-studied antibiotic for IBS-related bloating and suspected small intestinal bacterial overgrowth, secretagogues help when constipation is part of the picture, and brain-gut therapies are more useful than many patients realize.
"Today, the road to restoring a balanced microbiome appears the most promising solution," the 2024 review concluded, while also warning that stronger data are still needed for many microbiome-targeted therapies.
That said, the same review also emphasized an important limitation: most treatment studies were conducted in people with IBS, not in patients whose main complaint was isolated bloating, so some advice is extrapolated rather than proven directly. For that reason, the best evidence-based approach is still personalized care rather than blanket use of supplements or restrictive diets.
Best-supported treatments
Dietary therapy remains the usual first move, especially a short trial of reducing fermentable carbohydrates, lactose, fructose, or other obvious triggers. A traditional dietary advice pattern, with regular meals and less fat, alcohol, and caffeine, is often a practical first step before moving to a stricter low-FODMAP plan.
- Low-FODMAP or trigger-focused diet: best when bloating tracks specific foods or meals.
- Constipation treatment: best when bloating comes with infrequent stools, straining, or incomplete evacuation.
- Rifaximin: best-studied for IBS without constipation or suspected bacterial overgrowth-related bloating.
- Neuromodulators: useful when bloating is linked to visceral hypersensitivity, stress, or overlapping pain symptoms.
- Biofeedback or breathing retraining: helpful when visible distension is driven by abdomino-phrenic dyssynergia or pelvic-floor dysfunction.
Rifaximin has some of the clearest trial data. In the TARGET 1 and TARGET 2 trials, 39.5% vs. 28.7% and 41.0% vs. 31.9% of patients reported bloating relief with rifaximin compared with placebo, and the combined analysis favored treatment as well. Those numbers do not mean rifaximin is for everyone, but they do explain why it remains one of the most evidence-backed prescription options when bloating is part of IBS without constipation.
Constipation-focused treatment matters because bloating is often a retention problem, not just a gas problem. Reviews summarize that secretagogues such as lubiprostone, linaclotide, and plecanatide can improve bloating when constipation is present, likely by improving transit and reducing visceral sensitivity.
Practical treatment map
The most useful way to choose treatment is to match the symptom pattern to the likely mechanism. The table below summarizes the current evidence-based direction in plain language.
| Likely driver | Best-supported treatment | Why it helps | Evidence signal |
|---|---|---|---|
| Food-triggered bloating | Low-FODMAP or targeted dietary trial | Reduces fermentation and gas production | Moderate, strongest in IBS populations |
| Bloating with constipation | Osmotic laxatives, secretagogues, fiber optimization | Improves evacuation and stool transit | Good for constipation-linked bloating |
| IBS without constipation | Rifaximin | Modifies microbiota and gas production | Strongest prescription data |
| Meal-related bloating with pain or stress | Neuromodulators, CBT, gut-directed hypnotherapy | Reduces visceral hypersensitivity and brain-gut amplification | Promising, but less direct trial data for isolated bloating |
| Visible distension after meals | Breathing retraining, biofeedback | Targets abdomino-phrenic dyssynergia | Useful in selected patients |
What to try first
If you want the most evidence-based sequence, start with a short diet trial, then check whether constipation, diarrhea, or meal timing points to a more specific treatment. The 2024 microbiota review described a "targeted approach" as the most promising path, but also noted that strict long-term elimination diets can be hard to sustain and may disrupt nutrition or microbiome balance.
- Track symptoms for 1 to 2 weeks and identify whether bloating follows certain foods, large meals, or constipation.
- Try a short dietary intervention, such as regular-meal advice or a supervised low-FODMAP trial.
- If constipation is present, treat stool retention aggressively before assuming "gas" is the whole problem.
- If IBS without constipation or suspected SIBO is likely, discuss rifaximin with a clinician.
- If the abdomen visibly expands after meals, consider breathing work or biofeedback.
What is not as convincing
Probiotics are still controversial for bloating. The 2024 review said some targeted strains and mixed formulations looked promising, but overall evidence is inconsistent, and recent European and American guidance does not recommend probiotics as a routine bloating treatment.
Likewise, highly restrictive diets and random supplement stacks are not strongly supported for isolated bloating. The 2022 management review instead framed treatment around fermentation, transit, gas tolerance, and biofeedback, which is a more precise model than simply "reduce all bacteria" or "avoid all carbohydrates".
When to seek care
Most bloating is functional, but persistent or worsening symptoms deserve evaluation when they come with weight loss, vomiting, blood in stool, anemia, fever, severe pain, or a new change in bowel habits. Those features raise the odds of a structural or inflammatory cause and should not be treated as simple bloating.
Takeaway
The best treatment for bloating in light of new studies is not one pill or one diet; it is a mechanism-based plan that starts with dietary adjustment and then targets constipation, IBS/SIBO patterns, hypersensitivity, or distension mechanics. The most evidence-backed choices today are a short supervised diet trial, rifaximin for the right IBS subgroup, constipation-directed therapy when stool retention is present, and biofeedback or breathing exercises when visible distension is part of the problem.
Expert answers to Best Bloating Treatments New Studies Change Advice queries
Is a low-FODMAP diet the best treatment for bloating?
It is often the best first treatment when bloating is meal-related, because it reduces fermentable carbohydrates that feed gas production, but it is not the best fit for every patient. If constipation, pelvic-floor dysfunction, or IBS-related hypersensitivity is the real driver, other treatments may work better.
Does rifaximin really work for bloating?
Yes, rifaximin has some of the best trial evidence for bloating in IBS without constipation, with multiple phase 3 studies showing better relief than placebo. It is not a universal solution, but it is one of the most evidence-backed prescription options when the symptom pattern fits.
Are probiotics worth trying?
Maybe, but with caution. A 2024 review found promising signals for some strains, yet the overall evidence remains inconsistent, and major guidelines do not recommend probiotics routinely for bloating.
Why does bloating get worse after meals?
Post-meal bloating can come from fermentation, slowed transit, hypersensitivity, or an abnormal muscle response called abdomino-phrenic dyssynergia. That is why some patients improve with diet, while others improve more with breathing retraining, constipation treatment, or neuromodulators.